Iran starts third clinical trial phase of homegrown recombinant vaccine Razi Cov Pars for COVID-19

PressTV 13 views

Iran has started the third phase of the human trial of its second homegrown coronavirus vaccine, Razi Cov Pars, less than a week after Health Minister Bahram Einollahi said accelerating the pace of vaccination against COVID-19 is the top priority of the new administration.

Add Comments